Kadcyla

Kadcyla

Basic Prescribing Info
Contents
Trastuzumab emtansine
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD03 - trastuzumab emtansine ; Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in